Sustained Reduction in Cardiopulmonary Fitness in Long COVID: A Report from the RECOVER-adult Cohort Study
Long COVID is associated with worse cardiovascular fitness. Additional studies are needed to determine if Long COVID is a novel risk factor for incident CVD.
Still Treating Yesterday's Risk? Reconsidering Antiviral Use for Mild-to-Moderate COVID-19 Cases in a Broadly Immune Population
Comparing the Australian and New Zealand experiences in the evolving COVID-19 landscape highlights differences in policy and prescribing practice.
Long-term ocular symptoms following COVID-19 linked to immune dysregulation, dysautonomia and peripheral neuropathy
Using symptom and quality of life data, clinical examinations and biofluid proteomics, authors document ocular symptoms persisting from 3 months up to 3 years post-infection.
WHO: New global youth competition on influenza and COVID-19 prevention and control
Submissions will open on Monday 3 August 2026, until Sunday 13 September 2026.
News
Scientific Papers
Reports
How benchmarking of bioinformatics tools is essential for informed workflow selection: a case study on SARS-CoV-2 sgRNA detection
New report from the Joint Research Centre (JRC)
Euronews: Trump administration pulls Covid-19 vaccine safety studies
The US FDA has halted the publication of a number of scientific studies confirming vaccine safety.
Health Worker Influenza Vaccination Programs: A Key to Pandemic Preparedness and Effective COVID-19 Vaccine Deployment in Low- and Middle-Income Countries
Countries with established seasonal influenza vaccination programs were significantly better prepared to deploy COVID-19 vaccines.
Flu season is coming for Europe. How bad could it be this year?
It’s difficult to predict just how severe the influenza season will be each year, but public health experts say it could be harsh in Europe due to lagging vaccination rates and early signals from far-flung countries such as Japan and Australia.